title: Suboptimal inhibition of platelet aggregation following tirofiban bolus in patients undergoing percutaneous coronary intervention for unstable angina pectoris.
authors.affiliation: Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA. dsoffermd@aol.com
authors.forename: Daniel
authors.initials: D
authors.lastname: Soffer
authors.forename: Issam
authors.initials: I
authors.lastname: Moussa
authors.forename: Murat
authors.initials: M
authors.lastname: Karatepe
authors.forename: Kishore J
authors.initials: KJ
authors.lastname: Harjai
authors.forename: Judith
authors.initials: J
authors.lastname: Boura
authors.forename: Simon R
authors.initials: SR
authors.lastname: Dixon
authors.forename: Cindy L
authors.initials: CL
authors.lastname: Grines
authors.forename: William W
authors.initials: WW
authors.lastname: O'Neill
authors.forename: Gary S
authors.initials: GS
authors.lastname: Roubin
authors.forename: Jeffrey W
authors.initials: JW
authors.lastname: Moses
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000789:Angina, Unstable / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D015331:Cohort Studies; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009566:Nitrates / Q000627:therapeutic use; D015588:Observer Variation; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010976:Platelet Count; D000077466:Tirofiban; D016896:Treatment Outcome; D014443:Tyrosine / Q000031:analogs & derivatives / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D005343:Fibrinolytic Agents; D009566:Nitrates; D010975:Platelet Aggregation Inhibitors; D014443:Tyrosine; D006493:Heparin; D000077466:Tirofiban